IBEX Technologies Inc.
IBT
Peringkat dalam Saham
#28820
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Harga Saham
$1.05
Terakhir disinkronkan: 2024-04-11
Kapitalisasi Pasar
$23.31M
Perubahan (1 hari)
-0.01%
Perubahan (1 tahun)
5.21%
Negara
CA
Perdagangan IBEX Technologies Inc. (IBT)
Kategori
Healthcare
Kapitalisasi pasar dari IBEX Technologies Inc.(IBT)
Kapitalisasi Pasar: $23.31M
Per October 2026, IBEX Technologies Inc. memiliki kapitalisasi pasar sebesar $23.31M. Ini menjadikan IBEX Technologies Inc. sebagai perusahaan 28820th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar IBEX Technologies Inc. dari 2018 hingga 2026
IBT dibandingkan dengan 5 teratas stocks paling populer
